HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cetuximab: potential role as first-line treatment for advanced non-small cell lung cancer.

AuthorsRobert Pirker
JournalClinical advances in hematology & oncology : H&O (Clin Adv Hematol Oncol) Vol. 6 Issue 10 Pg. 735-6 (Oct 2008) ISSN: 1543-0790 [Print] United States
PMID18997663 (Publication Type: Interview)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • ErbB Receptors
  • Cetuximab
Topics
  • Antibodies, Monoclonal (therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents (therapeutic use)
  • Carcinoma, Non-Small-Cell Lung (drug therapy, metabolism)
  • Cetuximab
  • ErbB Receptors (antagonists & inhibitors, metabolism)
  • Humans
  • Lung Neoplasms (drug therapy, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: